The FDA has approved pretomanid tablets in combination with bedaquiline and linezolid for the treatment of adults with pulmonary XDR, treatment-intolerant or nonresponsive MDR tuberculosis.
New drugs cured two Ebola patients in Congo, showing that people can recover from the highly lethal disease if it is diagnosed and treated early.
The FDA has cleared for marketing the ZEUS Borrelia Modified Two-Tiered Testing algorithm to help in the diagnosis of Lyme disease.
Ceftobiprole was highly active against most clinical isolates of the major Gram-positive and Gram-negative skin and soft tissue infection pathogen groups.
A new antimicrobial agent, known as ADC56, has shown efficacy and selectivity in vitro and in vivo against Gram-negative pathogens.
Combinations of ibuprofen with aztreonam and ceftazidime display synergistic antimicrobial activity against drug-resistant Pseudomonas aeruginosa isolates in vitro, and efficacy of ceftazidime combined with ibuprofen was shown in vivo in a murine P aeruginosa pneumonia model, according to research presented at American Society of Microbiology (ASM) Microbe 2019 held from June 20-24, 2019 in San Francisco, California. Approximately…
The Food and Drug Administration has granted Fast Track designation to ABO-202 (Abeona Therapeutics Inc), a one-time adeno-associated virus 9 (AAV9) gene therapy for the treatment of CLN1 disease, also known as infantile neuronal ceroid lipofuscinosis or infantile Batten disease. CLN1 disease is a rapidly-progressing rare lysosomal storage disease caused by a defect in the…
Persistent detection of tumor-type HPV DNA during treatment tied to increased risk for recurrence, death
Treatment failure may be significantly reduced by a 3-month course of azithromycin for acute COPD exacerbations that require hospitalization.
The FDA’s Antimicrobial Drugs Advisory Committee voted in favor of pretomanid, as part of a combination regimen with bedaquiline and linezolid, for the treatment of pulmonary extensively drug resistant, treatment intolerant, or nonresponsive multidrug resistant tuberculosis.
